SKBI Share Price

Open 0.13 Change Price %
High 0.13 1 Day -0.04 -26.67
Low 0.11 1 Week -0.04 -26.67
Close 0.11 1 Month -0.11 -50.00
Volume 2991 1 Year -0.99 -90.00
52 Week High 1.25
52 Week Low 0.00
SKBI Important Levels
Resistance 2 0.13
Resistance 1 0.12
Pivot 0.12
Support 1 0.10
Support 2 0.09
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI)

SKBI Technical Analysis 5
As on 9th Dec 2016 SKBI Share Price closed @ 0.11 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.37 & Strong Sell for SHORT-TERM with Stoploss of 0.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
SKBI Target for December
1st Target up-side 0.27
2nd Target up-side 0.32
3rd Target up-side 0.37
1st Target down-side 0.13
2nd Target down-side 0.08
3rd Target down-side 0.03
SKBI Other Details
Segment EQ
Market Capital 14449120.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.skystarbio-pharmaceutical.com
SKBI Address
SKBI
Building B
4th Floor
Xi,
China
Phone: 86 29 8819 3188
SKBI Latest News
Interactive Technical Analysis Chart Skystar Bio-Pharmaceutical Company ( SKBI NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Skystar Bio-Pharmaceutical Company
SKBI Business Profile
Skystar Bio-Pharmaceutical Company (Skystar) is a holding company. The Company is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products. It has four product lines: micro-organism products line, which include over 16 products; veterinary medicine line for poultry and livestock, which includes over 245 products; feed additives line, which includes over 16 products, and bio-pharmaceutical veterinary vaccine line, which includes over 10 products. All of the Company�s operations are carried out by Xi�an Tianxing Bio-Pharmaceutical Co., Limited (Xi�an Tianxing), a People�s Republic of China (PRC) joint stock company that the Company controls through contractual arrangements originally between Skystar Bio-Pharmaceutical (Cayman) Holdings Co., Ltd. (Skystar Cayman) and Xi�an Tianxing. As of December 31, 2011, it had over 3,846 customers in 29 provinces in China.